- The Goswami Clinic
Is Regenerative Medicine Legit? Science vs. Hype
Medically reviewed by Dr. Gaurav Goswami, MD — prepared October 2026
Yes, regenerative medicine is a legitimate and active field of medical science, and several regenerative products have earned FDA approval. But the field also includes many treatments, especially some marketed directly to consumers, that have not been approved or proven. The best way to judge legitimacy is treatment by treatment: what exactly is being offered, what evidence supports it, and how honestly the provider explains both.
Contact Us
What Counts as Regenerative Medicine?
Regenerative medicine is a broad term for treatments intended to repair, replace, or regenerate damaged cells and tissues. It ranges from laboratory-grown tissue products to cell-based therapies to treatments that use components of a patient’s own blood, such as platelet-rich plasma.
Some regenerative products have completed the full FDA approval process. The FDA’s list of approved cellular and gene therapy products includes MACI, approved in 2016 to repair symptomatic, full-thickness cartilage defects of the knee in adults using cartilage cells grown from the patient’s own tissue on a scaffold. The list also includes umbilical cord blood products used for disorders of the blood-forming system. These examples show that regenerative medicine is not a fringe idea. It is an established area of research with real, approved therapies.
At the same time, approval is specific. MACI is surgically implanted for a defined type of cartilage injury; it is not the same thing as the injections many clinics offer for arthritis or back pain.
Contact Us
Why Does Regenerative Medicine Have a Mixed Reputation?
Much of the skepticism comes from the rapid growth of businesses selling unapproved treatments directly to consumers. A widely cited 2016 analysis in Cell Stem Cell identified 351 U.S. businesses marketing stem cell interventions directly to patients. According to a later study of direct-to-consumer stem cell businesses, the Southwest, including Southern California, accounted for roughly a third of that market, with Beverly Hills and Los Angeles among the national “hot spot” cities.
Marketing claims have often outpaced the science. One global review of stem cell business websites found that sites made broad, imprecise therapeutic claims and frequently failed to describe procedures in detail. And in a Journal of Knee Surgery survey, the 36 centers that shared success rates claimed an average marketed efficacy of 82.2%, a figure far more optimistic than the findings of independent systematic reviews. Of the 273 centers the researchers reached, most did not provide efficacy figures at all.
What Does the Evidence Actually Support?
For orthopedic stem cell injections, the evidence supports cautious optimism. The 2025 Cochrane review found, based on low-certainty evidence, that stem cell injections may slightly improve pain and function in knee osteoarthritis compared with placebo. Short-term safety data have been reassuring, but long-term evidence is still limited.
That combination of real signals and real uncertainty is exactly why reputable providers describe these treatments carefully. It is also why California requires practitioners who perform stem cell therapies that have not been approved by the FDA to post a specific notice in their offices and provide it to patients in writing before the first treatment. We explored this tension in our article on whether stem cell therapy is a controversy or a breakthrough.
What Red Flags Should Make You Pause?
Whatever treatment you’re considering, these warning signs deserve a closer look:
- Promises of a cure, guaranteed results, or very high success percentages.
- A long list of unrelated conditions treated with the same product, from arthritis to neurological or lung disease. The FDA notes that no regenerative product of this kind has been approved for those uses.
- A treatment recommendation or price quote before anyone has examined you or reviewed your imaging.
- Vague answers about where the cells come from, how they are processed, or how many are delivered.
- Wording that suggests FDA approval when there is none, such as describing a facility as “FDA-registered.” Registration of a facility is not the same as approval of a treatment.
- Pressure to commit quickly, including limited-time discounts.
- Patient testimonials offered in place of published evidence.
We take a closer look at one frequently misunderstood category in amniotic stem cells: facts vs. fiction.
What Are the Signs of a Trustworthy Practice?
Legitimate practices tend to share a recognizable set of habits:
- Care led by a physician with relevant, verifiable training, who performs the procedure personally.
- A diagnosis based on an exam and imaging before any treatment is discussed.
- Image guidance, using ultrasound or fluoroscopy, for injections.
- Clear explanations of FDA status, including California's stem cell notice.
- Realistic expectations, including honest discussion of who is not a good candidate.
- A written, itemized estimate before scheduling.
A trustworthy practice will also tell you when another specialist or treatment is the better fit, and it will put its recommendations, costs, and expectations in writing.
Our guide to questions to ask when considering stem cell therapy offers a practical checklist you can bring to any consultation.
How Does The Goswami Clinic Approach These Questions?
We believe patients deserve the full picture, including both the encouraging research and the open questions. Every treatment plan at The Goswami Clinic begins with a personalized evaluation, and our injections are performed using image guidance. You can read more about Dr. Goswami’s background, our approach to stem cell therapy, and why not all stem cell therapy is identical.
If you’d like a candid conversation about whether regenerative medicine makes sense for your condition, the first step is a free phone consultation.
Frequently Asked Questions
Is stem cell therapy a scam?
Not inherently. Stem cell science is legitimate, and some regenerative products are FDA-approved. The concern is with businesses that overstate results or sell unproven treatments without transparency, so it pays to judge each offering on its evidence and how honestly it’s described.
Are any regenerative treatments FDA-approved?
Yes. Examples on the FDA’s approved list include MACI for certain knee cartilage defects and umbilical cord blood products for disorders of the blood-forming system. The stem cell injections commonly offered for joint and back pain are not FDA-approved for those uses.
What does California's stem cell notice mean?
California law requires practitioners who perform stem cell therapies that are subject to FDA regulation but not FDA-approved to post a notice in their office and give it to patients in writing before the first treatment. The notice encourages patients to consult their primary care physician first. It is a disclosure requirement, not a finding that a treatment is unsafe.
How can I tell if a regenerative medicine clinic is reputable?
Look for physician-led care with verifiable training, a diagnosis based on an exam and imaging, image-guided procedures, honest discussion of FDA status and evidence, and a written estimate. Be cautious of guaranteed results or pressure to commit quickly.
Is PRP considered regenerative medicine?
Yes. PRP is commonly grouped under regenerative medicine because it uses concentrated platelets from your own blood to support healing. A 2025 pricing study found PRP was offered by nearly every practice it surveyed, and its evidence base, like that of stem cell therapy, continues to develop.
What is the difference between FDA-approved and FDA-registered?
FDA approval means the agency has reviewed evidence that a specific product is safe and effective for a specific use. Registration generally means a facility has listed itself with the FDA; it does not mean any treatment offered there has been reviewed or approved.
Why are there so many stem cell clinics in Southern California?
Research on the direct-to-consumer market has found that the Southwest, including Southern California, accounts for roughly a third of U.S. stem cell businesses, with Beverly Hills and Los Angeles among the national hot spots. With so many options, it is especially important to compare providers carefully.
Want an honest assessment of whether regenerative medicine fits your situation? Schedule a free phone consultation with our team.
